Acquired fibrinolytic defects

Description

A disease caused by determinants arising after birth, affecting the fibrinolysis system which prevents blood clots from growing and becoming problematic. This disease is characterised by defects in the fibrinolysis system leading to coagulation of the blood. This disease may present with thrombosis.

Index terms

Acquired fibrinolytic defects
Drug-induced fibrinolytic disorder
medicament-induced fibrinolytic disorder

Show allHide

Fibrinolytic disorder due to administration of tissue-type plasminogen activator
Fibrinolytic disorder due to administration of tPA - [ tissue-type plasminogen activator]
Fibrinolytic disorder due to administration of urokinase
Fibrinolytic disorder due to administration of other drugs

Exclusions from above levels

JA43.3 – Postpartum coagulation defects
04 – Diseases of the immune system
05 – Endocrine, nutritional or metabolic diseases

Show allHide

18 – Complications of pregnancy, childbirth or the puerperium
19 – Certain conditions originating in the perinatal period
20 – Congenital malformations, deformations or chromosomal abnormalities
22 – Injury, poisoning or certain other consequences of external causes
http://id.who.int/icd/entity/1000704511 – Human immunodeficiency virus disease
JB64.1 – Other diseases of the blood or blood-forming organs or certain disorders involving the immune mechanism complicating pregnancy, childbirth or the puerperium

Sibling codes

3B50 – Inherited fibrinolytic defects

Foundation entity

Acquired fibrinolytic defects – http://id.who.int/icd/entity/1845970455

Part of: 03: Diseases of the blood or blood-forming organs